tiprankstipranks
Odonate (ODTC)
OTHER OTC:ODTC
US Market
Holding ODTC?
Track your performance easily

Odonate (ODTC) Income Statement

281 Followers

Odonate Income Statement

Last quarter (Q3 2021), Odonate's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Odonate's net income was $-14.00M. See Odonate’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 20Dec 19Dec 18Dec 17Dec 16
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ -119.28M$ -127.43M$ -114.93M$ -90.76M$ 32.74M$ 3.08M
Operating Income
$ -102.32M$ -127.43M$ -114.93M$ -90.76M$ -32.74M$ -3.08M
Net Non Operating Interest Income Expense
$ -658.00K-$ 3.10M$ 1.80M$ 0.00-
Other Income Expense
$ -915.00K$ -1.08M$ -3.10M---
Pretax Income
$ -102.07M$ -126.35M$ -111.83M$ -88.96M$ -32.74M$ -3.08M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -102.07M$ -126.35M$ -111.83M$ -88.96M$ -32.74M$ -3.08M
Basic EPS
------
Diluted EPS
$ -2.68$ -3.84$ -8.10K$ -3.64--
Basic Average Shares
$ 146.11M$ 32.86M$ 13.81K$ 24.46M--
Diluted Average Shares
$ 152.05M$ 32.90M$ 13.80K$ 24.44M--
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -119.28M$ -127.43M$ -114.93M$ -90.76M$ 32.74M$ 3.08M
Net Income From Continuing And Discontinued Operation
$ -102.07M$ -126.35M$ -111.83M$ -88.96M$ -32.74M$ -3.08M
Normalized Income
----$ -32.74M$ -3.08M
Interest Expense
------
EBIT
$ -102.07M$ -126.35M$ -111.83M$ -88.96M$ -32.74M$ -3.08M
EBITDA
$ -101.60M$ -125.95M$ -111.42M$ -88.61M$ -32.72M$ -3.08M
Currency in USD

Odonate Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis